Advait Badkar

As Executive Director- DPDD (Head of Nanoparticle Development), Advait is accountable for drug product aspects for all the mRNA/LNP and the nanoparticle-based portfolio. The responsibilities include scientific, technical, strategic, and regulatory leadership of the area as well as specific programs. Advait is also accountable for establishing internal capabilities and expertise for nanoparticle formulation, process development, scale-up, tech transfer to enable clinical and commercial supplies. In addition to this, there is a focus on externally focused strategic alliances and collaborations. He also continues to lead the Drug Product Design and Development organization within Pfizer’s Biotherapeutics Pharmaceutical Sciences organization focused on identifying and developing drug product to support Pfizer’s entire biotherapeutics portfolio (proteins, monoclonals, vaccines, etc.) that focuses on all things related to Drug Product from the early Research stages up to Licensure including Commercial and Life Cycle Management support.


This speaker has made no appearances.